1,050
Views
0
CrossRef citations to date
0
Altmetric
Article

Expression of nAChRα7 receptor in model rats with Parkinson’s disease dementia

, , , , &
Pages 117-123 | Received 20 May 2020, Accepted 23 Sep 2020, Published online: 07 Dec 2020

References

  • Cacabelos R. Parkinson's disease: from pathogenesis to pharmacogenomics. Int J Mol Sci. 2017;18(3):551.
  • Fahn S. How do you treat motor complications in Parkinson's disease: medicine, surgery, or both? Ann Neurol. 2008;64(Suppl 2):S56–S64.
  • Kieburtz K. Therapeutic strategies to prevent motor complications in Parkinson's disease. J Neurol. 2008;255(Suppl 4):42–45.
  • Schapira AH, Emre M, Jenner P, et al. Levodopa in the treatment of Parkinson's disease. Eur J Neurol. 2009;16(9):982–989.
  • Stocchi F, Tagliati M, Olanow CW. Treatment of levodopa-induced motor complications. Mov Disord. 2008;23(Suppl 3):S599–S612.
  • Grando SA. Connections of nicotine to cancer. Nat Rev Cancer. 2014;14(6):419–429.
  • Liu Y, Zeng X, Hui Y, et al. Activation of α7 nicotinic acetylcholine receptors protects astrocytes against oxidative stress-induced apoptosis: implications for Parkinson's disease. Neuropharmacology. 2015;91:87–96. PubMed PMID: 25486621; eng.
  • Quik M, Zhang D, McGregor M, et al. Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease. Biochem Pharmacol. 2015;97(4):399–407. doi:.
  • Gratwicke J, Jahanshahi M, Foltynie T. Parkinson's disease dementia: a neural networks perspective. Brain. 2015;138(Pt 6):1454–1476.
  • Andriambeloson E, Huyard B, Poiraud E, et al. Methyllycaconitine- and scopolamine-induced cognitive dysfunction: differential reversal effect by cognition-enhancing drugs. Pharmacol Res Perspect. 2014;2(4):e00048.
  • Cheng L, Chen L, Wei X, et al. NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease. J Neuroinflammation. 2018;15(1):243.
  • Yan M, Chen H. A rat model of Parkinson's disease established by microinjection of 6 - hydroxydopamine into the different part of brain. J Pharm Pract. 2009;27(1):1–3.
  • Jing ZH, Wei XM, Wang SH, et al. The synergetic effects of nitric oxide and nicotinic acetylcholine receptor on learning and memory of rats. Sheng Li Xue Bao. 2014;66(3):307–314.
  • Li XY, Mei GH, Dong Q, et al. Enhanced neuroprotective effects of coadministration of tetrandrine with glutathione in preclinical model of Parkinson's disease. Parkinsons Dis. 2015;2015:931058. PubMed PMID: 26664824; PubMed Central PMCID: PMCPMC4667061.
  • Bali ZK, Nagy LV, Budai D, et al. Facilitation and inhibition of firing activity and N-methyl-D-aspartate-evoked responses of CA1 hippocampal pyramidal cells by alpha7 nicotinic acetylcholine receptor selective compounds in vivo. Sci Rep. 2019;9(1):9324.
  • Liao H, Fan J, Shen Q, et al. Alterations of interhemispheric functional connectivity in Parkinson's disease with depression: a resting-state functional MRI study. Front Hum Neurosci. 2020;14:193.
  • Smith C, Malek N, Grosset K, et al. Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry. 2019;90(11):1234–1243.
  • Titus DJ, Johnstone T, Johnson NH, et al. Positive allosteric modulation of the α7 nicotinic acetylcholine receptor as a treatment for cognitive deficits after traumatic brain injury. PLoS One. 2019;14(10):e0223180.
  • van Goethem NP, Paes D, Puzzo D, et al. Antagonizing α7 nicotinic receptors with methyllycaconitine (MLA) potentiates receptor activity and memory acquisition. Cell Signal. 2019;62:109338.
  • Tang X, Li Y, Ao J, et al. Role of α7nAChR-NMDAR in sevoflurane-induced memory deficits in the developing rat hippocampus. PLoS One. 2018;13(2):e0192498.
  • Pocivavsek A, Icenogle L, Levin ED. Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats. Psychopharmacology. 2006;188(4):597–604.
  • Fernandes C, Hoyle E, Dempster E, et al. Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory. Genes Brain Behav. 2006;5(6):433–440.
  • Zhang Y, Li Y, Wang Y, et al. Effects of resveratrol on learning and memory in rats with vascular dementia. Mol Med Rep. 2019;20(5):4587–4593.
  • Foyet HS, Keugong Wado E, Ngatanko Abaissou HH, et al. Anticholinesterase and antioxidant potential of hydromethanolic extract of Ziziphus mucronata (Rhamnaceae) leaves on scopolamine-induced memory and cognitive dysfunctions in mice. Evid Based Complement Alternat Med. 2019;2019:4568401.
  • Barrantes FJ, Bermudez V, Borroni MV, et al. Boundary lipids in the nicotinic acetylcholine receptor microenvironment. J Mol Neurosci. 2010;40(1-2):87–90.